$Successful treatment for refractory convulsive status epilepticus by non‐parenteral lacosamide$

Successful treatment for refractory convulsive status epilepticus by non‐parenteral lacosamide

Summary Lacosamide (Vimpat) is a newly licensed novel antiepileptic drug. We report a case of refractory convulsive status epilepticus (CSE) that was successfully controlled with lacosamide. The 38‐year‐old male patient was admitted for a series of complex partial seizures with secondary generalizat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Epilepsia (Copenhagen) 2010-02, Vol.51 (2), p.316-317
Hauptverfasser:	Tilz, Christian, Resch, Roland, Hofer, Thomas, Eggers, Christian
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetamides - administration & dosage Acetamides - adverse effects Acetamides - therapeutic use Adult Anticonvulsants - administration & dosage Anticonvulsants - adverse effects Anticonvulsants - therapeutic use Biological and medical sciences Convulsive status epilepticus Diazepam - administration & dosage Diazepam - therapeutic use Drug Resistance Drug Therapy, Combination Epilepsy - drug therapy Etomidate - therapeutic use Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Humans Lacosamide Male Medical sciences Midazolam - therapeutic use Nervous system (semeiology, syndromes) Neurology Neuropharmacology Neuroprotective agent Pharmacology. Drug treatments Piracetam - analogs & derivatives Piracetam - therapeutic use Practice Guidelines as Topic Refractory convulsive status epilepticus Status Epilepticus - drug therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!